Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Surges by 88%In a groundbreaking development, Adial Pharmaceuticals, Inc. (NASDAQ: NASDAQ:ADIL ) has unveiled promising findings in the treatment of Alcohol Use Disorder (AUD) with its lead investigational drug, AD04 (low-dose ondansetron). A recently published peer-reviewed article showcases the remarkable cli
−6.43USD
−7.75 MUSD
3.67 M
About Adial Pharmaceuticals, Inc
Sector
CEO
Cary J. Claiborne
Headquarters
Glen Allen
Website
Employees (FY)
7
Founded
2010
ISIN
US00688A2050
FIGI
BBG00HNGDTR4
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
ADIL - Retrace To Support - Good Entry?ADIAL saw an increase in volume and runup to 3.30 after which we saw a retrace to the 2.18 support level that held nicely. The upward trendline has been holding consistently on the daily and weekly charts. I am looking for a bullish engulfing or gap up opening with retrace to higher low to confirm t
$ADIL is gonna to fall todayPupm&Dump trading strategy idea.
$ADIL is rising without clear preconditions today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,10;
stop-loss — $2,35.
take-profit — $1,
ADIL: Next Target is $1.75 --> Bullish SupportFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, I am keeping a close watch on ADIL. It seems to have continued bullish support and looks like it can continue on a positive run all the until way next week for
Insider confidence in Adial Pharmaceuticals bodes wellAs Adial Pharmaceuticals advances its Phase 3 clinical trial of AD04 for the treatment of alcohol use, insiders are showing confidence in the company. Today they appointed Mark Howard Peikin as chief strategy officer, and he took the position without a salary. Instead, he accepted a stock option as
ADIL10:09 AM EDT, 09/11/2019 (MT Newswires) -- Adial Pharmaceuticals (ADIL) said Wednesday that it has successfully retested a previously manufactured supply of clinical trial packaged tablets of the investigational drug AD04 for the treatment of alcohol use disorder.
The company said tests showed that
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ADIL is 2.61 USD — it has increased by 12.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Adial Pharmaceuticals, Inc stocks are traded under the ticker ADIL.
Adial Pharmaceuticals, Inc is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Adial Pharmaceuticals, Inc has a max estimate of 8.00 USD and a min estimate of 7.00 USD.
ADIL earnings for the last quarter are −1.18 USD whereas the estimation was −1.28 USD which accounts for 7.45% surprise. Estimated earnings for the next quarter are −0.76 USD. See more details about Adial Pharmaceuticals, Inc earnings.
Yes, you can track Adial Pharmaceuticals, Inc financials in yearly and quarterly reports right on TradingView.
Like other stocks, ADIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adial Pharmaceuticals, Inc stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 7.00 employees. See our rating of the largest employees — is Adial Pharmaceuticals, Inc on this list?